RK21 SRL
RK21 reported total assets of 3,336 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).
The score of RK21 shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity -80 % Total assets -65 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
RK21's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 14 Jan 2025
RK21's financial analysis
- Solvency53.0%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of RK21
RK21's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0794.837.596
- VAT number
- BE0794837596
- Peppol
- Registered · 0208:0794837596 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Dec 2022
- Registered office
- 5362 Hamois
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
RK21 (SRL) has been based in Hamois since 2022, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net loss of 4,598 € and equity of 1,768 €; its revenue is not published. Its solvency stands at 53.0%, below the median of its sector (58.2%).
Companies similar to RK21
Companies in the same business, of comparable size and area, outside its group.
- Alanine Research and experimental development on natural sciences and engineering Lasne · balance sheet 28,321 €
- IQVIA Cancer Research Research and experimental development on natural sciences and engineering Zaventem · balance sheet €1.07m
- Bimsconsult Research and experimental development on natural sciences and engineering Auderghem · balance sheet 463,296 €
- LAB.001 Research and experimental development on natural sciences and engineering Brussels · balance sheet 5,303 €
- NASK Research and experimental development on natural sciences and engineering Dilbeek · balance sheet 2,027 €
- JCK Research and experimental development on natural sciences and engineering Montigny-le-Tilleul · balance sheet 1,364 €
- Phagomed Research and experimental development on natural sciences and engineering Izegem · balance sheet 8,901 €
- Indagen Research and experimental development on natural sciences and engineering Antwerp · balance sheet 10,059 €
Frequently asked questions about RK21
What is the revenue of RK21?
RK21 files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of RK21?
In Belgium, the VAT number is the company number prefixed with BE: BE0794837596 for RK21, if the company is VAT-registered. Its company number (CBE) is 0794.837.596.
Where is the registered office of RK21?
According to the CBE register, the registered office of RK21 is in 5362 Hamois.
What is the equity of RK21?
At the close of the 2025 financial year, the equity of RK21 amounts to 1,768 €, a solvency of 53.0% of total assets.
Who manages RK21?
The register lists 1 active mandates at RK21. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of RK21
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →